Finance

Lists
Why is 4564 down 5.56%?
Dive Deeper
4564:TYO
OncoTherapy Science, Inc.
ÂĄ17.00
-5.56%
(-1.00) 1D
Oct 29, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4564...
Open
ÂĄ18
High
ÂĄ18
Low
ÂĄ17
Mkt. cap
6.94B
Avg. vol.
182.17M
Volume
181.61M
52-wk high
ÂĄ34
52-wk low
ÂĄ17
EPS
-ÂĄ2
Shares outstanding
147.03M
No. of employees
46
Open
ÂĄ18
High
ÂĄ18
Low
ÂĄ17
Mkt. cap
6.94B
Avg. vol.
182.17M
Volume
181.61M
52-wk high
ÂĄ34
52-wk low
ÂĄ17
EPS
-ÂĄ2
Shares outstanding
147.03M
No. of employees
46
News stories
From web sources and news partners
About OncoTherapy Science, Inc.
CEO-
Employees46
FoundedApr 6, 2001
Headquarters-
SectorBiotechnology
Websiteoncotherapy.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
230.00M
166.00M
211.00M
170.00M
Cost of goods sold
301.00M
278.00M
362.00M
335.00M
Cost of revenue
301.00M
278.00M
362.00M
335.00M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
101.00M
107.00M
-36.00M
120.00M
Operating expense
101.00M
107.00M
-36.00M
120.00M
Total operating expenses
402.00M
385.00M
326.00M
455.00M
Operating income
-172.00M
-219.00M
-115.00M
-285.00M
Other non operating income
-7.00M
-6.00M
-8.00M
-1.00M
EBT including unusual items
-240.00M
-228.00M
-126.00M
-288.00M
EBT excluding unusual items
-180.00M
-226.00M
-125.00M
-287.00M
Income tax expense
1.00M
-
1.00M
-
Effective tax rate
-0.42%
-
-0.79%
-
Other operating expenses
-
-
-
-
Net income
-241.00M
-228.00M
-127.00M
-288.00M
Net profit margin
-104.78%
-137.35%
-60.19%
-169.41%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-1.00M
-
Net interest expenses
-
-
-1.00M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps